Baxter International Inc.

Healthcare

NYSE:BAX · New York Stock Exchange

Market Cap $10.01B Beta 0.64 P/E (TTM) -9.1

$19.89 -5.23%

-$1.07 today

52W Low $15.73High $31.76

Vol 5.60M · Avg 7.62M

EPS (TTM) -$2.13 Div Yield 1.03%Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-33.10%

Period High

$30.96

Period Low

$15.79

Latest

$19.89

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

DaVita Inc.

NYSE:DVA

$13.52B

Madrigal Pharmaceuticals, Inc.

NASDAQ:MDGL

$11.52B

Masimo Corporation

NASDAQ:MASI

$9.42B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.70B

AptarGroup, Inc.

NYSE:ATR

$7.66B

Qiagen N.V.

NYSE:QGEN

$7.54B

Repligen Corporation

NASDAQ:RGEN

$7.53B

Hims & Hers Health, Inc.

NYSE:HIMS

$7.11B

Avantor, Inc.

NYSE:AVTR

$6.46B

Atrium Therapeutics, Inc.

NASDAQ:RNA

$213.48M

What is the latest BAX filing?

The latest filing shown is SC 13G/A dated Jun 5, 2026.

How many recent filings does BAX have?

Intrinsic Alpha currently shows 20 recent filings for BAX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.